TickerFactsScreenerDevelopers

Inhibrx Biosciences, Inc. (INBX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$193.31M2024: -$194.41M2025: -$129.79M-$129.79M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$129.79M+33.2%
2024-$194.41M-0.6%
2023-$193.31M—